Free tool

Cell therapy stocks

We cover 18 companies grouped under the Cell therapy theme. The median market value in the group is $54.76M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −47.9% to +5.4% across the middle 80 percent of the group, with a median of −22.9%.

Other lists in this group

Table

18 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
4592.TSanBio Company Limited$504.78MSmall cap−55.46%
005690.KSPharmicell Co., Ltd.$490.77MSmall cap+1.06%
4894.TCuorips Inc.$300.07MSmall cap−20.84%
4593.THealios K.K.$258.92MSmall cap−43.33%
7774.TJapan Tissue Engineering Co., Ltd.$222.46MSmall cap+71.46%
504A.TInnovacell Inc.$153.38MSmall cap−48.38%
OCC.AXOrthocell Limited$147.97MSmall cap−36.82%
7776.TCellSeed Inc.$57.40MMicro cap−47.75%
4896.TK Pharma,Inc.$56.46MMicro cap+15.50%
ALA.AXArovella Therapeutics Limited$53.07MMicro cap−29.89%
7096.TStemCell Institute Inc.$47.97MMicro cap−20.83%
2370.TMEDINET Co., Ltd.$45.96MMicro cap−31.58%
3750.TADR Biomedical Holdings Inc.$43.76MMicro cap−14.54%
4880.TCellSource Co., Ltd.$42.67MMicro cap−43.02%
4893.TNoile-Immune Biotech Inc.$40.26MMicro cap−18.68%
4892.TCyfuse Biomedical K.K.$35.91MMicro cap−9.90%
CMB.AXCambium Bio Limited$8.90MMicro cap−10.64%
1AD.AXAdAlta Limited$6.94MMicro cap−25.00%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse